Technical Analysis for AMPE - Ampio Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 1.68 3.07% 0.05
AMPE closed up 3.07 percent on Monday, March 18, 2024, on 19 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Mar 25
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Outside Day Range Expansion 3.07%
Wide Bands Range Expansion 3.07%
Down 3 Days in a Row Weakness 3.07%
Down 4 Days in a Row Weakness 3.07%
Oversold Stochastic Weakness 3.07%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 9 hours ago
Up 3% about 9 hours ago
Possible NR7 about 10 hours ago
Rose Above 10 DMA about 14 hours ago
10 DMA Resistance about 15 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Ampio Pharmaceuticals, Inc. Description

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, engages in the discovery and development of pharmaceutical drugs and diagnostic products to identify, treat, and prevent metabolic disorders, eye diseases, kidney diseases, acute and chronic inflammation diseases, and male sexual dysfunction. Its products include Ampion, a non-steroidal anti-inflammatory biologic to treat inflammatory conditions and autoimmune diseases; Optina, an orally administered danazol for the treatment of diabetic macular edema; Vasaloc for the treatment of diabetic nephropathy; and Zertane, an oral drug for treating male sexual dysfunction to premature ejaculation, which is under Phase III clinical trial. The company is also developing a handheld oxidation-reduction potential diagnostic device for use at home or in healthcare facilities that will measure the oxidants/antioxidant balances in human blood and plasma; and methylphenidate derivatives for cancer, which are in pre-clinical development. Ampio Pharmaceuticals, Inc. is headquartered in Greenwood Village, Colorado.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Life Sciences Clinical Development Diabetes Eye Autoimmune Disease Inflammation Healthcare Facilities Kidney Disease Dysfunction Diagnostic Products Eye Diseases Macular Edema Diabetic Retinopathy Diabetic Macular Edema Metabolic Disorders Diabetic Nephropathy Antioxidant Methylphenidate Inflammatory Conditions Inflammation Diseases Male Sexual Dysfunction Sexual Dysfunction

Is AMPE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.298
52 Week Low 1.5
Average Volume 176,255
200-Day Moving Average 3.20
50-Day Moving Average 1.78
20-Day Moving Average 1.73
10-Day Moving Average 1.65
Average True Range 0.18
RSI (14) 48.45
ADX 37.65
+DI 28.09
-DI 13.48
Chandelier Exit (Long, 3 ATRs) 1.94
Chandelier Exit (Short, 3 ATRs) 2.03
Upper Bollinger Bands 2.07
Lower Bollinger Band 1.38
Percent B (%b) 0.43
BandWidth 40.27
MACD Line -0.04
MACD Signal Line -0.04
MACD Histogram 0.0018
Fundamentals Value
Market Cap 1.91 Million
Num Shares 1.14 Million
EPS -11.70
Price-to-Earnings (P/E) Ratio -0.14
Price-to-Sales 0.00
Price-to-Book 0.38
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.80
Resistance 3 (R3) 1.79 1.73 1.78
Resistance 2 (R2) 1.73 1.70 1.74 1.77
Resistance 1 (R1) 1.71 1.68 1.72 1.72 1.77
Pivot Point 1.65 1.65 1.66 1.66 1.65
Support 1 (S1) 1.63 1.62 1.64 1.64 1.59
Support 2 (S2) 1.57 1.60 1.58 1.59
Support 3 (S3) 1.55 1.57 1.58
Support 4 (S4) 1.56